rs35054425

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003640.5(ELP1):​c.1758T>G​(p.Pro586Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0147 in 1,613,206 control chromosomes in the GnomAD database, including 388 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0095 ( 10 hom., cov: 32)
Exomes 𝑓: 0.015 ( 378 hom. )

Consequence

ELP1
NM_003640.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.437

Publications

7 publications found
Variant links:
Genes affected
ELP1 (HGNC:5959): (elongator acetyltransferase complex subunit 1) The protein encoded by this gene is a scaffold protein and a regulator for three different kinases involved in proinflammatory signaling. The encoded protein can bind NF-kappa-B-inducing kinase and I-kappa-B kinases through separate domains and assemble them into an active kinase complex. Mutations in this gene have been associated with familial dysautonomia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
ELP1 Gene-Disease associations (from GenCC):
  • primary dysautonomia
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • Riley-Day syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • medulloblastoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 9-108902935-A-C is Benign according to our data. Variant chr9-108902935-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 364572.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.437 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0598 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ELP1NM_003640.5 linkc.1758T>G p.Pro586Pro synonymous_variant Exon 16 of 37 ENST00000374647.10 NP_003631.2
ELP1NM_001318360.2 linkc.1416T>G p.Pro472Pro synonymous_variant Exon 16 of 37 NP_001305289.1
ELP1NM_001330749.2 linkc.711T>G p.Pro237Pro synonymous_variant Exon 14 of 35 NP_001317678.1
ELP1XM_047423991.1 linkc.1758T>G p.Pro586Pro synonymous_variant Exon 16 of 25 XP_047279947.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ELP1ENST00000374647.10 linkc.1758T>G p.Pro586Pro synonymous_variant Exon 16 of 37 1 NM_003640.5 ENSP00000363779.5

Frequencies

GnomAD3 genomes
AF:
0.00951
AC:
1448
AN:
152232
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00207
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00923
Gnomad ASJ
AF:
0.0231
Gnomad EAS
AF:
0.000770
Gnomad SAS
AF:
0.0553
Gnomad FIN
AF:
0.00122
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0123
Gnomad OTH
AF:
0.00765
GnomAD2 exomes
AF:
0.0158
AC:
3961
AN:
251174
AF XY:
0.0186
show subpopulations
Gnomad AFR exome
AF:
0.00215
Gnomad AMR exome
AF:
0.00640
Gnomad ASJ exome
AF:
0.0228
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00120
Gnomad NFE exome
AF:
0.0124
Gnomad OTH exome
AF:
0.0160
GnomAD4 exome
AF:
0.0153
AC:
22339
AN:
1460856
Hom.:
378
Cov.:
30
AF XY:
0.0169
AC XY:
12282
AN XY:
726800
show subpopulations
African (AFR)
AF:
0.00203
AC:
68
AN:
33448
American (AMR)
AF:
0.00658
AC:
294
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.0229
AC:
599
AN:
26120
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39694
South Asian (SAS)
AF:
0.0612
AC:
5274
AN:
86184
European-Finnish (FIN)
AF:
0.00144
AC:
77
AN:
53418
Middle Eastern (MID)
AF:
0.0304
AC:
175
AN:
5766
European-Non Finnish (NFE)
AF:
0.0134
AC:
14875
AN:
1111152
Other (OTH)
AF:
0.0161
AC:
972
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
974
1949
2923
3898
4872
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
612
1224
1836
2448
3060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00950
AC:
1447
AN:
152350
Hom.:
10
Cov.:
32
AF XY:
0.00948
AC XY:
706
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.00207
AC:
86
AN:
41584
American (AMR)
AF:
0.00921
AC:
141
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0231
AC:
80
AN:
3470
East Asian (EAS)
AF:
0.000965
AC:
5
AN:
5184
South Asian (SAS)
AF:
0.0553
AC:
267
AN:
4824
European-Finnish (FIN)
AF:
0.00122
AC:
13
AN:
10630
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0123
AC:
835
AN:
68034
Other (OTH)
AF:
0.00757
AC:
16
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
73
147
220
294
367
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0108
Hom.:
10
Bravo
AF:
0.00849
Asia WGS
AF:
0.0260
AC:
90
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 14, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 22, 2017
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: The IKBKAP c.1758T>G (p.Pro586Pro) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. One in silico tool predicts a polymorphism outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. ESE finder predicts that this variant may affect ESE sites. However, these predictions have yet to be confirmed by functional studies. This variant was found in 1977/119930 control chromosomes (50 homozygotes) at a frequency of 0.0164846, which is approximately 9 times the estimated maximal expected allele frequency of a pathogenic IKBKAP variant (0.001838), suggesting this variant is likely a benign polymorphism. In addition, one clinical diagnostic laboratory classified this variant as benign and another lab classified it as uncertain significance, all without evidence for independent evaluation. The variant of interest has not, to our knowledge, been reported in affected individuals via publications; nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as benign. -

Familial dysautonomia Benign:3
May 18, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

May 10, 2017
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
4.4
DANN
Benign
0.52
PhyloP100
-0.44
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35054425; hg19: chr9-111665215; COSMIC: COSV107487492; API